 |
 |

Evaluation of Clostridium difficile–Associated Disease Pressure as a Risk Factor for C difficile–Associated Disease
Erik R. Dubberke, MD;
Kimberly A. Reske, MPH;
Margaret A. Olsen, PhD;
Kathleen M. McMullen, MPH;
Jennie L. Mayfield, MPH;
L. Clifford McDonald, MD;
Victoria J. Fraser, MD
Arch Intern Med. 2007;167(10):1092-1097.
Background Colonization pressure has been identified as an important risk factor in the transmission of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus species, but the role of colonization pressure in the transmission of Clostridium difficile–associated disease (CDAD) is unclear. The purpose of this study was to evaluate CDAD pressure, a modified form of colonization pressure based on symptomatic CDAD cases, as a risk factor for CDAD.
Methods Retrospective cohort and nested case-control studies of patients admitted to Barnes-Jewish Hospital from January 1, 2003, through December 31, 2003. Univariate analysis and multivariate logistic regression models were used to evaluate the role of CDAD pressure as a risk factor for CDAD.
Results A total of 36 275 patients were included in the cohort, of which 382 had CDAD. The median CDAD pressure was higher for case patients than noncase patients (1.4 vs 0.3; P<.001), and only 1 patient with CDAD had a CDAD pressure of 0. In the nested case-control study, CDAD pressure remained an independent risk factor for CDAD after adjustment for demographics, severity of illness, medications received (chemotherapy, gastric acid suppressors, antidiarrheals or narcotics, and antibiotics), and abdominal procedures or surgery performed.
Conclusions The results of this study suggest that CDAD pressure may be an independent risk factor for CDAD. Future studies that evaluate risk of CDAD should control for CDAD pressure.
Author Affiliations: Department of Medicine, Washington University School of Medicine (Drs Dubberke, Olsen, and Fraser and Ms Reske), and Department of Infection Control, Barnes-Jewish Hospital (Mss McMullen and Mayfield), St Louis, Mo; and Centers for Disease Control and Prevention, Atlanta, Ga (Dr McDonald).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Stevens et al.
Clinical Infectious Diseases 2011;53:42-48.
ABSTRACT
| FULL TEXT
The Changing Epidemiology of Clostridium difficile Infections
Freeman et al.
Clin. Microbiol. Rev. 2010;23:529-549.
ABSTRACT
| FULL TEXT
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Linsky et al.
Arch Intern Med 2010;170:772-778.
ABSTRACT
| FULL TEXT
Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile
Johnston and Bryce
CMAJ 2009;180:627-631.
FULL TEXT
Clostridium difficile Infections in a Canadian Tertiary Care Hospital before and during a Regional Epidemic Associated with the BI/NAP1/027 Strain
Labbe et al.
Antimicrob. Agents Chemother. 2008;52:3180-3187.
ABSTRACT
| FULL TEXT
Reply to Goorhuis et al
Dubberke et al.
Clinical Infectious Diseases 2008;47:430-431.
FULL TEXT
Clostridium difficile--Associated Disease in a Setting of Endemicity: Identification of Novel Risk Factors
Dubberke et al.
Clinical Infectious Diseases 2007;45:1543-1549.
ABSTRACT
| FULL TEXT
Confronting Clostridium difficile in Inpatient Health Care Facilities
McDonald
Clinical Infectious Diseases 2007;45:1274-1276.
FULL TEXT
|